Valneva price target lowered to $20 from $23 at H.C. Wainwright
PremiumThe FlyValneva price target lowered to $20 from $23 at H.C. Wainwright
29d ago
Valneva Outlines Future Growth and Vaccine Pipeline
Premium
Company Announcements
Valneva Outlines Future Growth and Vaccine Pipeline
30d ago
Valneva Announces Investor Day to Showcase Vaccine Pipeline
Premium
Company Announcements
Valneva Announces Investor Day to Showcase Vaccine Pipeline
1M ago
Valneva, Pfizer say Phase 2 Lyme disease vaccine study positive
PremiumThe FlyValneva, Pfizer say Phase 2 Lyme disease vaccine study positive
2M ago
Valneva Advances Lyme Disease Vaccine Candidate
Premium
Company Announcements
Valneva Advances Lyme Disease Vaccine Candidate
2M ago
Valneva Reports Solid H1 2024 Results and Pipeline Growth
Premium
Company Announcements
Valneva Reports Solid H1 2024 Results and Pipeline Growth
3M ago
Pfizer, Valneva announce vaccination series completion in VALOR trial
PremiumThe FlyPfizer, Valneva announce vaccination series completion in VALOR trial
4M ago
Valneva’s Chikungunya Vaccine Wins European Approval
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Wins European Approval
4M ago
Valneva Strengthens Board, Shareholders Back Plans
Premium
Company Announcements
Valneva Strengthens Board, Shareholders Back Plans
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100